David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Carnival Corporation Ltd
CCL
$35B
| $1.11M | ﹤0.01% |
21,926
-410,454
| -95% | -$22.7M |
|
2502
Reinsurance Group of America
RGA
$16.1B
| $1.11M | ﹤0.01% |
7,832
-4,044
| -34% | -$582K |
|
2503
ICU Medical
ICUI
$4.49B
| $1.11M | ﹤0.01% |
4,634
-2,619
| -36% | -$628K |
|
2504
CALL
Motorola Solutions
MSI
$80.6B
| $1.11M | ﹤0.01% |
7,900
| – | – |
|
2505
CALL
Tactile Systems Technology
TCMD
$533M
| $1.1M | ﹤0.01% |
20,900
-1,700
| -8% | -$110K |
|
|
AAWW
2506
PUT
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $1.1M | ﹤0.01% |
21,800
+12,500
| +134% | +$633K |
|
2507
Quad
QUAD
$515M
| $1.1M | ﹤0.01% |
92,420
-43,516
| -32% | -$584K |
|
|
ELGX
2508
DELISTED
Endologix Inc
ELGX
| $1.1M | ﹤0.01% |
166,434
-27,749
| -14% | -$183K |
|
|
ZGNX
2509
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $1.1M | ﹤0.01% |
20,000
-25,000
| -56% | -$1.19M |
|
|
MZTI
2510
The Marzetti Company
MZTI
$3.1B
| $1.1M | ﹤0.01% |
7,013
+2,501
| +55% | +$402K |
|
2511
CALL
Archer Daniels Midland
ADM
$38.6B
| $1.1M | ﹤0.01% |
+25,400
| New | +$1.09M |
|
|
XHR
2512
Xenia Hotels & Resorts
XHR
$1.78B
| $1.09M | ﹤0.01% |
+49,879
| New | +$950K |
|
2513
Transocean
RIG
$6.25B
| $1.09M | ﹤0.01% |
125,394
-674,915
| -84% | -$5.78M |
|
|
SAND
2514
DELISTED
Sandstorm Gold
SAND
| $1.09M | ﹤0.01% |
199,467
-64,477
| -24% | -$340K |
|
2515
CALL
Vodafone
VOD
$36.8B
| $1.09M | ﹤0.01% |
60,000
+34,900
| +139% | +$647K |
|
2516
CALL
Xerox
XRX
$391M
| $1.09M | ﹤0.01% |
+34,100
| New | +$962K |
|
|
SLCA
2517
PUT
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.09M | ﹤0.01% |
62,800
-339,800
| -84% | -$4.87M |
|
2518
Twist Bioscience
TWST
$9.41B
| $1.09M | ﹤0.01% |
46,994
+1,989
| +4% | +$44.9K |
|
2519
CALL
TTEC Holdings
TTEC
$68M
| $1.09M | ﹤0.01% |
30,000
| – | – |
|
2520
Codexis
CDXS
$181M
| $1.08M | ﹤0.01% |
+52,782
| New | +$1.03M |
|
2521
Movado Group
MOV
$781M
| $1.08M | ﹤0.01% |
29,804
-6,400
| -18% | -$215K |
|
2522
Simmons First National
SFNC
$3.29B
| $1.08M | ﹤0.01% |
+44,138
| New | +$1.13M |
|
|
JNCE
2523
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.08M | ﹤0.01% |
173,808
+80,032
| +85% | +$387K |
|
2524
Leggett & Platt
LEG
$1.26B
| $1.08M | ﹤0.01% |
25,516
-20,578
| -45% | -$865K |
|
2525
Ameris Bancorp
ABCB
$5.76B
| $1.08M | ﹤0.01% |
31,329
-33,913
| -52% | -$1.26M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.